全文获取类型
收费全文 | 26789篇 |
免费 | 1766篇 |
国内免费 | 104篇 |
专业分类
耳鼻咽喉 | 326篇 |
儿科学 | 449篇 |
妇产科学 | 376篇 |
基础医学 | 3537篇 |
口腔科学 | 806篇 |
临床医学 | 2814篇 |
内科学 | 5423篇 |
皮肤病学 | 637篇 |
神经病学 | 2709篇 |
特种医学 | 1411篇 |
外国民族医学 | 2篇 |
外科学 | 4120篇 |
综合类 | 219篇 |
一般理论 | 17篇 |
预防医学 | 1860篇 |
眼科学 | 594篇 |
药学 | 1578篇 |
中国医学 | 63篇 |
肿瘤学 | 1718篇 |
出版年
2023年 | 186篇 |
2022年 | 374篇 |
2021年 | 721篇 |
2020年 | 473篇 |
2019年 | 589篇 |
2018年 | 702篇 |
2017年 | 560篇 |
2016年 | 735篇 |
2015年 | 848篇 |
2014年 | 1067篇 |
2013年 | 1334篇 |
2012年 | 2040篇 |
2011年 | 1940篇 |
2010年 | 1179篇 |
2009年 | 1031篇 |
2008年 | 1729篇 |
2007年 | 1782篇 |
2006年 | 1647篇 |
2005年 | 1587篇 |
2004年 | 1380篇 |
2003年 | 1276篇 |
2002年 | 1156篇 |
2001年 | 370篇 |
2000年 | 312篇 |
1999年 | 360篇 |
1998年 | 233篇 |
1997年 | 202篇 |
1996年 | 140篇 |
1995年 | 119篇 |
1994年 | 99篇 |
1993年 | 91篇 |
1992年 | 178篇 |
1991年 | 142篇 |
1990年 | 168篇 |
1989年 | 121篇 |
1988年 | 134篇 |
1987年 | 126篇 |
1986年 | 101篇 |
1985年 | 113篇 |
1984年 | 94篇 |
1983年 | 73篇 |
1982年 | 77篇 |
1979年 | 83篇 |
1978年 | 69篇 |
1975年 | 57篇 |
1974年 | 53篇 |
1973年 | 74篇 |
1972年 | 58篇 |
1971年 | 51篇 |
1969年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Widder Randolf A. Lappas Alexandra Rennings Corinna Hild Matthias Roessler Gernot F. Dietlein Thomas S. 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2020,258(11):2581-2581
Graefe's Archive for Clinical and Experimental Ophthalmology - The published online version contains mistake as the author's first name and last name have been interchanged as "Hild... 相似文献
2.
3.
4.
5.
6.
7.
The association between family affluence and smoking among 15‐year‐old adolescents in 33 European countries,Israel and Canada: the role of national wealth
下载免费PDF全文
![点击此处可从《Addiction (Abingdon, England)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
8.
Tobias Kisch Julia Maria Klemens Katharina Hofmann Eirini Liodaki Matthias Gierloff Dirk Moellmeier Felix Stang Peter Mailaender Jens Habermann Matthias Brandenburger 《Medicine》2015,94(41)
The regrowth of amputated digit tips represents a unique regenerative healing in mammals with subcutaneous volume regrowth, restoration of dactylogram, and suppression of scar formation. Although factor analysis in amphibians and even in mice is easy to obtain, safety of harvesting biomaterial from human digit tip amputations for analysis has not yet been described.The aim of this study was to evaluate if recovering wound exudate does hamper clinical outcome or influence microbiologic or inflammation status.A predefined cohort of 18 patients with fresh digit tip amputations was randomly assigned to receive standard therapy (debridement, occlusive dressing) with (n = 9) or without (n = 9) collection of the whole wound exudate in every dressing change. Primary endpoint (lengthening) and secondary endpoints (regeneration of dactylogram, nail bed and bone healing, time to complete wound closure, scar formation, 2-point discrimination, microbiologic analysis, inflammatory factors interleukin (IL)-1α, tumor necrosis factor-α, IL-4, and IL-6) were determined by an independent, blinded observer.Patients’ characteristics showed no significant differences between the groups. All patients completed the study to the end of 3 months follow-up. Exudate collection did not influence primary and secondary endpoints. Furthermore, positive microbiologic findings as well as pus- and necrosis-like appearance neither impaired tissue restoration nor influenced inflammatory factor release.Here, the authors developed an easy and safe protocol for harvesting wound exudate from human digit tip amputations. For the first time, it was shown that harvesting does not impair regenerative healing. Using this method, further studies can be conducted to analyze regeneration associated factors in the human digit tip.DRKS.de Identifier: DRKS00006882 (UTN: U1111-1166-5723). 相似文献
9.
Susan C. Fox Jane A. May Natalia Dovlatova Jackie R. Glenn Andrew Johnson Ann E. White 《Platelets》2019,30(3):290-295
Measurement of P-selectin on activated platelets as a means of measuring platelet function utilizing the technology described here has the advantage of not requiring immediate access to specialist equipment and expertise. Blood samples are activated, fixed, stored, and transported to a central laboratory for flow cytometric analysis. Here we have compared P-selectin with other more traditional approaches to measuring platelet function in blood and/or platelet-rich plasma (PRP) from patients with acute coronary syndromes on treatment for at least 1 month with either aspirin and clopidogrel or aspirin with prasugrel. The comparators were light transmission aggregometry (LTA), VerifyNow and Multiplate aggregometry (for determining the effects of aspirin) and LTA, VerifyNow and Multiplate together with the BioCytex VASP phosphorylation assay (for the P2Y12 antagonists). The P-selectin Aspirin Test revealed substantial inhibition of platelet function in all but three of 96 patients receiving aspirin with clopidogrel and in none of 51 patients receiving aspirin and prasugrel. The results were very similar to those obtained using LTA. There was only one patient with high residual platelet aggregation and low P-selectin expression. The same patients identified as “non-responders” to aspirin also presented with the highest residual platelet activity as measured using the VerifyNow system, although not quite as well separated from the other values. With the Multiplate test only one of these patients clearly stood out from the others. The results obtained using the P-selectin P2Y12 Test in 102 patients taking aspirin and clopidogrel were similar to the more traditional approaches in that a wide scatter of results was obtained. Generally, high values seen with the P-selectin P2Y12 Test were also high with the LTA, VerifyNow, Multiplate, and BioCytex VASP P2Y12 Tests. Similarly, low residual platelet function using the P2Y12 test was seen irrespective of the testing procedure used. However, there were differences in some patients. Prasugrel was always more effective than clopidogrel in inhibiting platelet function with none of 56 patients (P-selectin and VerifyNow), only 2 of 56 patients (Multiplate) and only 3 of 56 patients (Biocytex VASP) demonstrating high on-treatment residual platelet reactivity (HRPR) defined using previously published cut-off values. The exception was LTA where there were 11 of 56 patients with HRPR. It remains to be seen which experimental approach provides the most useful information regarding outcomes after adjusting therapies in treated patients. 相似文献
10.
C. Jacquet F. Goehringer E. Baux J.A. Conrad M.O. Ganne Devonec J.L. Schmutz G. Mathey H. Tronel T. Moulinet I. Chary-Valckenaere T. May C. Rabaud 《Médecine et maladies infectieuses》2019,49(2):112-120